483
CSL Plasma IncCSL Plasma Inc – FDA 483, Apr 29, 2026
Record Details
An FDA inspection of CSL Plasma Inc's plasmapheresis center in Milwaukee, WI, identified a significant issue regarding donor notification. The firm failed to properly inform a permanently deferred donor of all relevant test results, specifically omitting results from a subsequent collection and certain test results from both collections. This indicates a lapse in the firm's donor communication procedures.
- Person
View Company Profile
ID · 07675b01-47b3-4113-86cf-5c34b2e27fd7
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.